论文部分内容阅读
目的探讨胺碘酮在转复快速房颤中的治疗体会。方法选取我院2014年10月至2016年10月收治并已确诊的转复快速房颤患者100例,回顾性分析所选患者的临床资料,所选患者均给予胺碘酮治疗。治疗后对其不良反应、心室率以及转复率的情况进行观察记录。结果治疗2h后患者转复率在30%,6h内转复率在56%,12h内的转复率在70%;心室率改善显著;未出现严重副反应。结论在转复快速房颤中应用胺碘酮治疗的临床效果确切,有效安全,建议在临床治疗中进行推广与应用。
Objective To investigate the treatment of amiodarone in the rapid atrial fibrillation. Methods A total of 100 patients with fast AF who had been admitted to our hospital from October 2014 to October 2016 were retrospectively analyzed. The clinical data of selected patients were retrospectively analyzed. Amiodarone was given to all patients. After treatment, the adverse reactions, ventricular rate and recovery rate were observed and recorded. Results After 2 hours of treatment, the rate of reversion was 30%, the rate of reversion was 56% within 6 hours, the rate of reversion was 70% within 12 hours, and the ventricular rate was significantly improved. No serious side effects occurred. Conclusions The clinical effect of amiodarone in the treatment of rapid atrial fibrillation is accurate, effective and safe. It is suggested that it should be promoted and applied in clinical treatment.